UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Vertebral Fractures: Clinical Importance and Management

The American journal of medicine, 2016-02, Vol.129 (2), p.221.e1-221.e10

2016

Volltextzugriff (PDF)

Percutaneous creation of jump bypass grafts in failing arteriovenous hemodialysis fistulas in 9 patients

Journal of vascular and interventional radiology, 2014-03, Vol.25 (3), p.S171-S171

2014

Volltextzugriff (PDF)

33 Bone Mineral Density and Fracture Risk in Chronic Kidney Disease

Journal of clinical densitometry, 2009, Vol.12 (1), p.111-111

Miller, P.D

2009

Volltextzugriff (PDF)

On the algebraic solutions of the Painlevé-III (D7) equation

Physica. D, 2022-12, Vol.441, p.133493, Article 133493

2022

Volltextzugriff (PDF)

The diffusion equation with nonlocal data

Journal of mathematical analysis and applications, 2018-10, Vol.466 (2), p.1119-1143

2018

Volltextzugriff (PDF)

Dynamical Hamiltonian–Hopf instabilities of periodic traveling waves in Klein–Gordon equations

Physica. D, 2015-07, Vol.308, p.87-93

2015

Volltextzugriff (PDF)

Dispersive hydrodynamics: Preface

Physica. D, 2016-10, Vol.333, p.1-5

2016

Volltextzugriff (PDF)

Efficacy and safety of denosumab vs. bisphosphonates in postmenopausal women previously treated with oral bisphosphonates

Osteoporosis international, 2020, Vol.31 (1), p.181-191

2020

Volltextzugriff (PDF)

Bone mineral density response rates are greater in patients treated with abaloparatide compared with those treated with placebo or teriparatide: Results from the ACTIVE phase 3 trial

Bone (New York, N.Y.), 2019-03, Vol.120, p.137-140

2019

Volltextzugriff (PDF)

Abaloparatide effect on forearm bone mineral density and wrist fracture risk in postmenopausal women with osteoporosis

Osteoporosis international, 2019-06, Vol.30 (6), p.1187-1194

2019

Volltextzugriff (PDF)

PMS79 PHASE 1B EVALUATION OF PATIENT EXPERIENCE WITH ABALOPARATIDE SOLID MICROSTRUCTURED TRANSDERMAL SYSTEM IN POSTMENOPAUSAL WOMEN WITH LOW BONE MINERAL DENSITY

Value in health, 2020-05, Vol.23, p.S229-S229

2020

Volltextzugriff (PDF)

Further reductions in nonvertebral fracture rate with long-term denosumab treatment in the FREEDOM open-label extension and influence of hip bone mineral density after 3 years

Osteoporosis international, 2015-12, Vol.26 (12), p.2763-2771

2015

Volltextzugriff (PDF)

Comparison of bone architecture via micro-ct after long-term treatment with risedronate and alendronate: A cross-sectional study in women with postmenopausal osteoporosis

Bone (New York, N.Y.), 2008-03, Vol.42, p.S70-S70

2008

Volltextzugriff (PDF)

Abstract No. 387 - Percutaneous creation of jump bypass grafts in failing arteriovenous hemodialysis fistulas in 9 patients

Journal of vascular and interventional radiology, 2014-03, Vol.25 (3), p.S171-S171

2014

Volltextzugriff (PDF)

A pooled analysis demonstrates IV ibandronate injection is associated with a favorable renal safety profile

Journal of clinical densitometry, 2007, Vol.10 (2), p.S218-S218

2007

Volltextzugriff (PDF)

Long-term denosumab treatment restores cortical bone loss and reduces fracture risk at the forearm and humerus: analyses from the FREEDOM Extension cross-over group

Osteoporosis international, 2019-09, Vol.30 (9), p.1855-1864

2019

Volltextzugriff (PDF)

Western Osteoporosis Alliance Clinical Practice Series: Evaluating the balance of benefits and risks of long-term osteoporosis therapies

The American journal of medicine, 2017-07, Vol.130 (7), p.862.e1-862.e7

2017

Volltextzugriff (PDF)

Persistent Fracture Reduction with Abaloparatide-SC (TYMLOS™) Followed by 24 Months of Alendronate

Journal of clinical densitometry, 2018-10, Vol.21 (4), p.606-607

2018

Volltextzugriff (PDF)

Monthly ibandronate use is associated with a high percentage of BMD responders

Journal of clinical densitometry, 2007, Vol.10 (2), p.S219-S219

2007

Volltextzugriff (PDF)

Efficacy and adverse event profile of monthly oral ibandronate during the first year of the mobile long-term extension study

Journal of clinical densitometry, 2007, Vol.10 (2), p.S217-S217

2007

Volltextzugriff (PDF)

The impact of subject demographics on young adult DXA Z-scores

Journal of clinical densitometry, 2007, Vol.10 (2), p.S207-S207

2007

Volltextzugriff (PDF)

OP0248 Responder Analysis of the Effects of Abaloparatide (Parathyroid Hormone Related Peptide) and Teriparatide on Bone Mineral Density in Postmenopausal Women with Osteoporosis: Results of the Active Trial

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.165-166

2015

Volltextzugriff (PDF)

Cooled thermotherapy (TUMT) for chronic abacterial prostatitis (CP/CPPS): 2 years after treatment

Urology (Ridgewood, N.J.), 2005-09, Vol.66 (3), p.23-23

2005

Volltextzugriff (PDF)

Fracture Risk among Women with Discordance of BMD measurements at Hip and Spine: Evidence from National Osteoporosis Risk Assessment (NORA)

Journal of clinical densitometry, 2006-04, Vol.9 (2), p.230-230

2006

Volltextzugriff (PDF)

BMD Improvements in Postmenopausal Osteoporosis: MOBILE Shows Continued Superiority of Once-Monthly Ibandronate at 2 Years

Journal of clinical densitometry, 2006-04, Vol.9 (2), p.248-248

2006

Volltextzugriff (PDF)

1 – 25 von 398

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(320)
Mit Volltextzugriff
(360)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(398)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Vertebral Fractures: Clinical Importance and Management

Percutaneous creation of jump bypass grafts in failing arteriovenous hemodialysis fistulas in 9 patients

33 Bone Mineral Density and Fracture Risk in Chronic Kidney Disease

On the algebraic solutions of the Painlevé-III (D7) equation

The diffusion equation with nonlocal data

Dynamical Hamiltonian–Hopf instabilities of periodic traveling waves in Klein–Gordon equations

Dispersive hydrodynamics: Preface

Efficacy and safety of denosumab vs. bisphosphonates in postmenopausal women previously treated with oral bisphosphonates

Bone mineral density response rates are greater in patients treated with abaloparatide compared with those treated with placebo or teriparatide: Results from the ACTIVE phase 3 trial

Abaloparatide effect on forearm bone mineral density and wrist fracture risk in postmenopausal women with osteoporosis

PMS79 PHASE 1B EVALUATION OF PATIENT EXPERIENCE WITH ABALOPARATIDE SOLID MICROSTRUCTURED TRANSDERMAL SYSTEM IN POSTMENOPAUSAL WOMEN WITH LOW BONE MINERAL DENSITY

Further reductions in nonvertebral fracture rate with long-term denosumab treatment in the FREEDOM open-label extension and influence of hip bone mineral density after 3 years

Comparison of bone architecture via micro-ct after long-term treatment with risedronate and alendronate: A cross-sectional study in women with postmenopausal osteoporosis

Abstract No. 387 - Percutaneous creation of jump bypass grafts in failing arteriovenous hemodialysis fistulas in 9 patients

A pooled analysis demonstrates IV ibandronate injection is associated with a favorable renal safety profile

Long-term denosumab treatment restores cortical bone loss and reduces fracture risk at the forearm and humerus: analyses from the FREEDOM Extension cross-over group

Western Osteoporosis Alliance Clinical Practice Series: Evaluating the balance of benefits and risks of long-term osteoporosis therapies

Persistent Fracture Reduction with Abaloparatide-SC (TYMLOS™) Followed by 24 Months of Alendronate

Monthly ibandronate use is associated with a high percentage of BMD responders

Efficacy and adverse event profile of monthly oral ibandronate during the first year of the mobile long-term extension study

The impact of subject demographics on young adult DXA Z-scores

OP0248 Responder Analysis of the Effects of Abaloparatide (Parathyroid Hormone Related Peptide) and Teriparatide on Bone Mineral Density in Postmenopausal Women with Osteoporosis: Results of the Active Trial

Cooled thermotherapy (TUMT) for chronic abacterial prostatitis (CP/CPPS): 2 years after treatment

Fracture Risk among Women with Discordance of BMD measurements at Hip and Spine: Evidence from National Osteoporosis Risk Assessment (NORA)

BMD Improvements in Postmenopausal Osteoporosis: MOBILE Shows Continued Superiority of Once-Monthly Ibandronate at 2 Years

Suchergebnisse filtern